US7312339B2ExpiredUtilityPatentIndex 47
Polyene oxazoles and processes for their preparation
Assignee: THALLION PHARMACEUTICALS INCPriority: Jun 13, 2003Filed: Jun 14, 2004Granted: Dec 25, 2007
Est. expiryJun 13, 2023(expired)· nominal 20-yr term from priority
C07D 413/12A61P 35/00C12P 17/14C12R 2001/60C07D 263/32C12N 1/205
47
PatentIndex Score
1
Cited by
16
References
16
Claims
Abstract
Polyene oxazoles of the following formula wherein R 3 is selected from H and methyl, are disclosed. Such compounds, and pharmaceutically acceptable salts thereof, may be used in the inhibition of tumor cell growth. The polyene oxazoles and their pharmaceutically acceptable salts may be formulated as pharmaceutical compositions with pharmaceutically acceptable carriers for use in the inhibition of tumor cells. The polyene oxazoles may be obtained from strains of Streptomyces sparsogenes , such as strain 022 having deposit number IDAC 270504-04.
Claims
exact text as granted — not AI-modified1. A compound of the formula
wherein R 3 is selected from H and methyl; or a pharmaceutically acceptable salt thereof.
2. A compound of the formula
or a pharmaceutically acceptable salt thereof.
3. A compound of the formula
or a pharmaceutically acceptable salt thereof.
4. A pharmaceutical composition comprising compound of the formula
wherein R 3 is selected from H and methyl; or a pharmaceutically acceptable salt thereof, together with a pharmaceutically acceptable carrier.
5. A pharmaceutical composition comprising a compound of the formula
or a pharmaceutically acceptable salt thereof, together with a pharmaceutically acceptable carrier.
6. A pharmaceutical composition comprising a compound of the formula
or a pharmaceutically acceptable salt thereof, together with a pharmaceutically acceptable carrier.
7. A polyene oxazole obtained by a method comprising
(a) cultivating a Streptomyces sparsogenes strain, wherein said cultivation is performed under aerobic conditions in a nutrient medium comprising at least one source of carbon atoms and at least one source of nitrogen atoms; and
(b) isolating a polyene oxazole from the strain cultivated in step (a), wherein said polyene oxazole is a compound of the formula
8. A polyene oxazole obtained by a method comprising
(a) cultivating a Streptomyces sparsogenes strain, wherein said cultivation is performed under aerobic conditions in a nutrient medium comprising at least one source of carbon atoms and at least one source of nitrogen atoms; and
(b) isolating a polyene oxazole from the strain cultivated in step (a), wherein said polyene oxazole is a compound of the formula
9. A process for making the compound of claim 1 , comprising the steps of cultivation of a Streptomyces sparsogenes strain, in a nutrient medium comprising at least one source of carbon atoms and at least one source of nitrogen atoms, and isolation and purification said compound.
10. The process of claim 9 , wherein said Streptomyces sparsogenes strain is NRRL 2940 or a mutant thereof.
11. The process of claim 10 , wherein said mutant is strain [S03]022 (deposit accession number IDAC 270504-04).
12. The process of claim 9 wherein cultivation occurs under aerobic conditions.
13. The process of claim 9 wherein said nutrient medium is a media selected from the group consisting of media DA, DZ, ET, JA, MY, NA, QB and VB as set forth in the table below:
Component
DA
DZ
ET
JA
MY
NA
QB
VB
Glucose
10
5
6
10
Sucrose
20
Maltose
4
Cane molasses
10
10
60
10
20
Soluble starch
5
15
20
5
Corn starch
30
Potatoe dextrin
20
Corn steep solids
5
2.5
Corn steep liquid
15
Malt extract
35
10
Yeast extract
4
Pharmamedia
15
5
Glycerol
10
20
Soybean flour
5
Soytonpeptone
5
Fish meal
10
20
Bacto-peptone
1
MgSO 4 •7H 2 O
0.5
CaCO 3 * 1
3
5
2
2
4
2.5
FeCl 2 •4H 2 O
0.1
Nal
0.5
ZnCl 2
0.1
MnCl 2 •4H 2 O
0.1
CuSO 4 •5H 2 O
0.1
Phytic acid
1
Casamino acid
5
Porflo oil
2
Ingredients are in gm/L The pH is adjusted to 7 except where indicated
* 1 pH adjusted to 7.3 prior to the addition of CaCO 3 .
14. The process of claim 9 wherein said cultivation is carried out at a temperature ranging from 18° C. to 40° C.
15. The process of claim 9 wherein said cultivation is carried out at a pH ranging from 6 to 9.
16. Streptomyces sparsogenes having IDAC accession number 270504-04.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.